Tonix Pharmaceuticals Holding (TNXP) Net Margin (2022 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Net Margin came in at 584.38% in Q1 2026, up 10845.0% year-on-year from N/an in Q1 2025, and up 32.85% quarter-over-quarter from 870.32% in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Net Margin (2022 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Net Margin history runs 5 years deep, the most recent figure standing at 584.38% for Q1 2026.
- On a quarterly basis, Net Margin rose 10845.0% year-over-year to 584.38% in Q1 2026; TTM through Mar 2026 was 839.52%, a 47435.0% increase from a year earlier, with the FY2025 full-year figure at 946.22%, up 34203.0% from the prior year.
- Net Margin advanced to 584.38% in Q1 2026 per TNXP's latest filing, from 870.32% in the prior quarter.
- Across five years, Net Margin topped out at 503.65% in Q3 2024 and bottomed at 3567.75% in Q2 2024.
- The 5-year median for Net Margin is 760.14% (2023), against an average of 976.09%.
- Across the five-year window, Net Margin slumped 276764 bps in 2024 and jumped 215274 bps in 2025, its largest moves.
- Year by year, Net Margin stood at 797.28% in 2022, then gained by 9 bps to 723.0% in 2023, then fell by 18 bps to 856.24% in 2024, then declined by 2 bps to 870.32% in 2025, then jumped by 33 bps to 584.38% in 2026.
- Per Business Quant, the three latest TNXP Net Margin figures stand at 584.38% (Q1 2026), 870.32% (Q4 2025), and 972.95% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 15.02% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | -584.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -584.38% |
| Dec 31, 2025 | -870.32% |
| Sep 30, 2025 | -972.95% |
| Jun 30, 2025 | -1,415.02% |
| Mar 31, 2025 | -692.84% |
| Dec 31, 2024 | -856.24% |
| Sep 30, 2024 | -503.65% |
| Jun 30, 2024 | -3,567.75% |
| Mar 31, 2024 | -601.89% |
| Dec 31, 2023 | -723.00% |
| Sep 30, 2023 | -701.30% |
| Jun 30, 2023 | -800.11% |
| Sep 30, 2022 | -797.28% |
| Jun 30, 2022 | -578.56% |